
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Lung Cancer Update
00:00
The Pacific Trial: A Step Forward in the Adjuvant Setting
I think this trial I mean it's great to have now really long term follow up on the Pacific trial that has tasted a lot. There are a number of ways to try to improve the pacific regime by doing that concurrently or using some more let's say intensifying immunotherapy using combinations with the volume map and I think the course trial is a step forward on that direction. We're not curing enough people yet to feel comfortable pulling back but that's where we need to be happy. louis covered us new development small cell speaker of anti-c2a4 pd1 derva plus tremy from asmo looking at that strategy. This is incredibly exciting we've been waiting for
Transcript
Play full episode